Author: Mitani Yasumasa Lezhava Alexander Sakurai Aki Horikawa Akina Nagakura Makoto Hayashizaki Yoshihide Ishikawa Toshihisa
Publisher: Future Medicine
ISSN: 1462-2416
Source: Pharmacogenomics, Vol.10, Iss.7, 2009-07, pp. : 1187-1197
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
DPP-IV inhibitors could be cost-effective for T2DM
Inpharma, Vol. 1, Iss. 1642, 2008-01 ,pp. :
DPP-IV inhibitors could be cost-effective for T2DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 556, 2008-01 ,pp. :